Guest commentator Mark Orton presents a dark view of the future following the 2016 presidential election.
Anita Harris of New Cambridge Observer writes that Ariana Pharma opens Ariana Data Intelligence, Inc., in Cambridge. Ariana offers “KEM” non-statistical analysis technology to streamline and to cut financial risk of clinical trials.
Rather than engage in namecalling and derision, I’ll quit now –and simply thank whomever built Mr. Snowman for your neighborliness and sense of fun. You really brightened my day!
Here’s a summary, compiled by the stats helper monkeys at WordPress.com, who mulled over how this blog did in 2010. Five thousand views… Thanks, wordpress, readers, and the Boston Globe! I promise to be more diligent in 2011.